DALLAS, Sept. 19, 2011 /PRNewswire/ -- Securities lawyers
at Goldfarb Branham LLP are investigating whether board of
directors of Caliper Life Sciences (NASDAQ: CALP) violated
shareholder protection laws in its proposed buyout by PerkinElmer,
Inc. (NASDAQ: PKI) for $10.50 per
share. Concerned investors are encouraged to contact attorney
Hamilton Lindley at 877-583-2855 or hlindley@goldfarbbranham.com
about their rights and remedies.
"The offer represents a premium of 42% for CALP shareholders,
but the company reported on September 7,
2011 that it has $34 million
as a result of organic growth, which is up 24% for the first half
of the year. The buyout will result in a cash out for
shareholders while CEO Robert F.
Friel remains with the company," securities lawyer Hamilton
Lindley said. "Our proposed class action lawsuit seeks to ensure
that the investors received reasonable value and information in
this buyout."
Goldfarb Branham LLP lawyers have significant experience
representing shareholders and whistleblowers in securities lawsuits
nationwide. CALP investors – or anyone with knowledge about this
acquisition – should contact lawyer Hamilton Lindley at
hlindley@goldfarbbranham.com or 877-583-2855.
Hamilton Lindley
Goldfarb Branham LLP
2501 N. Harwood, Ste. 1801
Dallas, TX 75201
(877) 583-2855 Toll Free Telephone
(214) 583-2233 Local Phone Number
(214) 583-2234 Fax Number
hlindley@goldfarbbranham.com
www.goldfarbbranham.com
SOURCE Goldfarb Branham LLP